Iqvia Holdings (IQV) Cash from Investing Activities (2012 - 2026)
Iqvia Holdings' (IQV) quarterly Cash from Investing Activities came in at -$381.0 million in Q2 2026, down 10.12% year-over-year from -$423.9 million in Q2 2025, and down 94.39% quarter-over-quarter from -$196.0 million in Q1 2026.
Analysis
Iqvia Holdings (IQV) Cash from Investing Activities (2012 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Cash from Investing Activities across 15 years of filings, most recently posting -$381.0 million for Q2 2026.
- In Q2 2026, Cash from Investing Activities fell 10.12% year-over-year to -$381.0 million; the TTM figure through Jun 2026 stood at -$2.2 billion (down 43.01% YoY), while the FY2025 annual figure was -$2.3 billion, down 59.63% from the prior year.
- Cash from Investing Activities came in at -$381.0 million for Q2 2026 at Iqvia Holdings, down from -$196.0 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of -$196.0 million in Q1 2026 to a low of -$1.1 billion in Q4 2025.
- Average Cash from Investing Activities over 5 years is -$440.8 million, with a median of -$363.5 million recorded in 2025.
- Year-over-year, Cash from Investing Activities jumped 63.78% in 2023 and plunged 256.13% in 2025.
- Over 5 years, Cash from Investing Activities stood at -$477.0 million in 2022, then soared by 55.56% to -$212.0 million in 2023, then slumped by 46.23% to -$310.0 million in 2024, then sank by 256.13% to -$1.1 billion in 2025, then soared by 65.49% to -$381.0 million in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$381.0 million in Q2 2026, -$196.0 million in Q1 2026, and -$1.1 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | -381.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | -23.89 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | -108.34 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 28.10 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | -7.00 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 11.09 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -55,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -55,941.69 |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -23,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -381.00 Mn |
| Mar 31, 2026 | -196.00 Mn |
| Dec 31, 2025 | -1.10 Bn |
| Sep 30, 2025 | -550.00 Mn |
| Jun 30, 2025 | -346.00 Mn |
| Mar 31, 2025 | -305.00 Mn |
| Dec 31, 2024 | -310.00 Mn |
| Sep 30, 2024 | -599.00 Mn |
| Jun 30, 2024 | -221.00 Mn |
| Mar 31, 2024 | -314.00 Mn |
| Dec 31, 2023 | -212.00 Mn |
| Sep 30, 2023 | -573.00 Mn |
| Jun 30, 2023 | -596.00 Mn |
| Mar 31, 2023 | -222.00 Mn |
| Dec 31, 2022 | -477.00 Mn |
| Sep 30, 2022 | -717.00 Mn |
| Jun 30, 2022 | -199.00 Mn |
| Mar 31, 2022 | -613.00 Mn |
| Dec 31, 2021 | -647.00 Mn |
| Sep 30, 2021 | -1.10 Bn |